Haidi Wu

Oct 24, 2024 | virologyj.biomedcentral.com | Haidi Wu |Jiaxin Tian |Wenbo Shi |Zhi Ye Wang |Yanjun Du |Hongwei Xu | +8 more

In this observational, real-world study, patients who received tixagevimab/cilgavimab from July 9, 2022, to December 30, 2022, in Hainan, China, were included. The inclusion criteria were patients who received tixagevimab/cilgavimab either before the initiation of the study or were prescribed with tixagevimab/cilgavimab thereafter. The patients participating in interventional clinical trials for SARS-CoV-2 prophylactics or treatments were excluded.

Sep 5, 2024 | onlinelibrary.wiley.com | Jun Yan |Tao J. Cui |Qin Su |Haidi Wu

1 Introduction Recently, great achievements have been made in solar-driven interfacial evaporation (SDIE) technology, as it makes use of both inexhaustible solar energy and abundant seawater resources, showing the potential to solve the growing scarcity of freshwater.[1-4] Much effort has been focused on optimizing thermal localization to maximize the utilization of heat energy,[5-7] regulating the water supply to ensure the efficiency and sustainability of SDIE,[8-11] reducing the equivalent...